U.S. RESEARCH ROUNDUP- Altice USA, Kinnate Biopharma, Omeros

Kinnate Biopharma

27/09/2021 07:55

Sept 27 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Altice USA, Kinnate Biopharma and Omeros on Monday. 
    
    HIGHLIGHTS
     * Altice USA Inc  ATUS.N : Credit Suisse cuts to neutral from outperform
     * Kinnate Biopharma Inc  KNTE.O : Jefferies initiates coverage with buy rating 
     * Omeros Corp  OMER.O : JP Morgan initiates coverage with neutral rating and PT of $15
        
Following is a summary of research actions on U.S. companies reported by Reuters on Monday.
Stock entries are in alphabetical order. 
    
     * Aemetis Inc  AMTX.O : Ascendiant Capital Markets raises target price to $33 from $20
     * Altice USA Inc  ATUS.N : Credit Suisse cuts target price to $24 from $46
     * Altice USA Inc  ATUS.N : Credit Suisse cuts to neutral from outperform
     * Atara Biotherapeutics Inc  ATRA.O : JP Morgan assumes coverage with overweight rating 
     * Atara Biotherapeutics Inc  ATRA.O : JP Morgan assumes coverage with $26 target price
     * Aterian Inc  ATER.O : Alliance Global Partners raises target price to $14 from $9
     * Aterian Inc  ATER.O : D.A. Davidson raises target price to $14 from $7
     * Chewy Inc  CHWY.N : Credit Suisse assumes coverage with outperform rating and $121 PT
     * Costco Wholesale Corp  COST.O : Credit Suisse raises target price to $490 from $400
     * Darden Restaurants Inc  DRI.N : Stephens raises target price to $180 from $170
     * Elevate Credit Inc  ELVT.N : Credit Suisse raises target price to $6 from $5.60
     * Essex Property Trust Inc  ESS.N : JP Morgan raises target price to $359 from $327
     * Franklin Resources Inc  BEN.N : Jefferies raises target price to $35 from $32
     * Gamestop Corp  GME.N : Ascendiant Capital Markets cuts target price to $24 from $25
     * Genetron Holdings Ltd  GTH.O : BTIG cuts target price to $21 from $25
     * Kinnate Biopharma Inc  KNTE.O : Jefferies initiates coverage with buy rating 
     * Kinnate Biopharma Inc  KNTE.O : Jefferies initiates coverage with $46 target price
     * Lennar Corp  LEN.N : JP Morgan raises target price to $143 from $141
     * Magnolia Oil & Gas Corp  MGY.N : Truist Securities raises target price to $22 from $21
     * Mesa Laboratories Inc  MLAB.O : JP Morgan raises target price to $320 from $280
     * Nextplay Technologies  NXTP.O : Ascendiant Capital Markets raises PT to $6.50 from $5.75
     * Nio Inc  NIO.N : HSBC cuts target price to $47 from $69
     * Omeros Corp  OMER.O : JP Morgan initiates coverage with neutral rating and PT of $15
     * Prothena Corporation Plc  PRTA.O : Oppenheimer raises target price to $100 from $90
     * Stevanato Group SpA  STVN.N : Jefferies raises target price to $34.50 from $28
     * Tenneco Inc  TEN.N : Jefferies cuts target price to $17 from $20
 

 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))